Purple Biotech .(PPBT) - 2023 Q1 - Quarterly Report

Exhibit 99.1 Purple Biotech Reports Fourth Quarter and Full-Year 2022 Financial Results Expands pipeline with acquisition of new tri-specific antibodies Data readouts for two lead clinical programs expected in 2023 REHOVOT, Israel, February 8, 2023 – (GLOBE NEWSWIRE) Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies that harness the power of the tumor microenvironment to overcome tumor immune evasi ...